Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Semisynthetic ecteinascidins presented in recent patent issued to U. of Illinois

Nov. 3, 1999

Celecoxib in FAP: results of clinical trial discussed at ACG

Nov. 2, 1999

AxyS Pharmaceuticals licenses rights to Signal's SERM-beta compounds for cancer indications

Nov. 2, 1999

Development of antisense-containing regimen for malignant melanoma to be fast-tracked

Oct. 29, 1999

Paracure gets notice of allowance for patent covering modified arglabin compounds

Oct. 29, 1999

CPMP gives favorable opinion on Taxotere for advanced non-small cell lung cancer

Oct. 28, 1999

Additional positive data reported for Cell Pathways' exisulind

Oct. 28, 1999

First macrolide LHRH antagonists patented by Abbott

Oct. 28, 1999

New distamycin derivatives developed at Pharmacia & Upjohn for cancer Rx

Oct. 28, 1999

Dramatic results described for STI-571 in CML patients

Oct. 27, 1999

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.